Exosomal molecules | Origin of exosomes | Mechanisms | Potential effects | References |
---|---|---|---|---|
miR-214-3p | Osteoclast | Targeting osterix and ATF4 (osteogenic transcriptional factors) | Inhibition of osteogenic differentiation and bone formation | [46] |
lncRNA-MALAT1 | Endothelial progenitor cell (EPC) | Expressing miR-124 excessively to reverse the migration of bone marrow-derived macrophages and osteoclastic differentiation | Positive recruitment of osteoclast precursors and promotion of their differentiation | [47] |
Bone marrow stromal cell (BMSC) | Mediating miR-34c/SATB2 axis | Enhancement of osteoblast activity | [48] | |
Protein-Fas | Mesenchymal stem cell (MSC) | Downregulating miR-29b levels to recover Dnmt1-mediated programs | Restoration of the osteogenic differentiation ability of MRL/lpr BMMSCs | [49] |
miR-31a-5p | Bone marrow stromal cell (BMSC) | Promoting osteoclast formation and bone resorption | Stimulation of osteoclast differentiation and function | [50] |
miR-155 | Vascular endothelial cell (EC) | Internalizing vascular EC-secreted exosomes with bone marrow-derived macrophages (BMMs) to inhibit osteoclast activity | Suppression of osteoclast induction | [51] |
miR-1192, miR-680, miR-302a, miR-3084-3p, miR-680, miR-677-3p and miR-5100 | Mineralizing osteoblasts (MOB) | Targeting Ctnnb1 converging on the β-catenin gene | Promotion of osteogenesis and differentiation of ST2 cells into osteoblast-like cells | [52] |
miR-667-3p, miR-6769b-5p, miR-7044-5p, miR-7668-3p and miR-874-3p | Mineralizing osteoblasts (MOB) | Repressing Axin1 to inhibit Wnt/β-catenin signaling |